Search research articles
Contact Us
Filters
Showing results (91-100 of 110) with videos related to
Page
of 11
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
February 3, 2024
Multiplexed high-throughput immune cell imaging in patients with high-risk triple negative early breast cancer: Analysis from the International Breast Cancer Study Group (IBCSG) Trial 22-00
S Rusakiewicz, S Tyekucheva, S Tissot-Renaud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2020
ESO-ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4)
S Paluch-Shimon, F Cardoso, A H Partridge, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 13, 2007
Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group
G Ryan, G Martinelli, M Kuper-Hommel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 4, 2018
Temozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients bearing MGMT methylation
F Morano, S Corallo, M Niger, et al.
ESMO Open
|
January 17, 2026
A tailored histology-driven molecular profiling algorithm proposal for salivary gland cancers
S Alfieri, S Rota, R Romanò, et al.
ESMO Open
|
October 30, 2025
Impact of molecular tests and precision oncology on patients with advanced thyroid carcinomas in a referral center: the OrienTHYring real-world study
E Colombo, S Cavalieri, A Vingiani, et al.
NPJ Breast Cancer
|
December 2, 2025
HER2-low breast cancer is immune-cold: insights into tumor-infiltrating immune cells and implications for immunotherapy
S Pizzamiglio, A Blanda, V Appierto, et al.
ESMO Open
|
July 2, 2023
A three-gene signature marks the time to locoregional recurrence in luminal-like breast cancer
C Chiodoni, S Sangaletti, M Lecchi, et al.
Nature Communications
|
December 3, 2024
Loss of NUMB drives aggressive bladder cancer via a RHOA/ROCK/YAP signaling axis
F A Tucci, R Pennisi, D C Rigiracciolo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 7, 2022
ESO-ESMO fifth international consensus guidelines for breast cancer in young women (BCY5)
S Paluch-Shimon, F Cardoso, A H Partridge, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 110) with videos related to
Sort By:
Page
of 11
European Journal of Cancer (Oxford, England : 1990)
|
February 3, 2024
Multiplexed high-throughput immune cell imaging in patients with high-risk triple negative early breast cancer: Analysis from the International Breast Cancer Study Group (IBCSG) Trial 22-00
S Rusakiewicz, S Tyekucheva, S Tissot-Renaud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2020
ESO-ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4)
S Paluch-Shimon, F Cardoso, A H Partridge, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 13, 2007
Primary diffuse large B-cell lymphoma of the breast: prognostic factors and outcomes of a study by the International Extranodal Lymphoma Study Group
G Ryan, G Martinelli, M Kuper-Hommel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 4, 2018
Temozolomide and irinotecan (TEMIRI regimen) as salvage treatment of irinotecan-sensitive advanced colorectal cancer patients bearing MGMT methylation
F Morano, S Corallo, M Niger, et al.
ESMO Open
|
January 17, 2026
A tailored histology-driven molecular profiling algorithm proposal for salivary gland cancers
S Alfieri, S Rota, R Romanò, et al.
ESMO Open
|
October 30, 2025
Impact of molecular tests and precision oncology on patients with advanced thyroid carcinomas in a referral center: the OrienTHYring real-world study
E Colombo, S Cavalieri, A Vingiani, et al.
NPJ Breast Cancer
|
December 2, 2025
HER2-low breast cancer is immune-cold: insights into tumor-infiltrating immune cells and implications for immunotherapy
S Pizzamiglio, A Blanda, V Appierto, et al.
ESMO Open
|
July 2, 2023
A three-gene signature marks the time to locoregional recurrence in luminal-like breast cancer
C Chiodoni, S Sangaletti, M Lecchi, et al.
Nature Communications
|
December 3, 2024
Loss of NUMB drives aggressive bladder cancer via a RHOA/ROCK/YAP signaling axis
F A Tucci, R Pennisi, D C Rigiracciolo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 7, 2022
ESO-ESMO fifth international consensus guidelines for breast cancer in young women (BCY5)
S Paluch-Shimon, F Cardoso, A H Partridge, et al.
Page
of 11